Interactions 2025, hosted by NICE, is scheduled for June 16-18, 2025, at the Aria Hotel in Las Vegas. This conference focuses on advancements in customer experience (CX) and offers attendees ...

Cost-effectiveness watchdog NICE has recommended Lytenava as an option for wet AMD in adults who have signs of recent disease progression, no permanent structural damage to the central fovea ...

Gilead Sciences and Kite, a Gilead company, have announced that the National Institute for Health and Care Excellence (NICE) has recommended Yescarta (axicabtagene ciloleucel; axi-cel) for routine ...

Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy (terminated appraisal) TA1068 29 May 2025 29 May 2025 Nivolumab plus ipilimumab for ...